CTMX CytomX Therapeutics, Inc.

Fundamentals / CIK 0001501989 / USD

CytomX Therapeutics, Inc. reported $14.03M in revenue and a net loss of $85.42M for the trailing twelve months ended September 30, 2026 (down 71.7% year over year), with a -676.5% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CTMX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$148.4M$74.18M$0-$120.1MFY 2016 Revenue: $15.04MFY 2016 Net Income: -$58.90M2016FY 2017 Revenue: $71.62MFY 2017 Net Income: -$43.10M2017FY 2018 Revenue: $59.50MFY 2018 Net Income: -$84.60M2018FY 2019 Revenue: $57.49MFY 2019 Net Income: -$102.2M2019FY 2020 Revenue: $100.4MFY 2020 Net Income: -$32.88M2020FY 2021 Revenue: $37.31MFY 2021 Net Income: -$115.9M2021FY 2022 Revenue: $53.16MFY 2022 Net Income: -$99.32M2022FY 2023 Revenue: $101.2MFY 2023 Net Income: -$569K2023FY 2024 Revenue: $138.1MFY 2024 Net Income: $31.87M2024FY 2025 Revenue: $76.20MFY 2025 Net Income: -$17.37M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $76.20M $138.1M $101.2M $53.16M $37.31M $100.4M $57.49M $59.50M $71.62M $15.04M
Research & Development $68.73M $83.38M $77.68M $111.6M $114.2M $112.9M $131.6M $103.9M $92.28M $54.76M
Total Operating Expenses $98.56M $113.1M $107.7M $154.5M $153.4M $149.0M $168.4M $137.4M $117.9M $74.63M
Operating Income -$22.36M $25.00M -$6.48M -$101.3M -$116.0M -$48.60M -$110.9M -$77.87M -$46.26M -$59.59M
EBITDA -$21.02M $26.74M -$4.34M -$98.89M -$113.3M -$46.06M -$108.2M -$75.99M -$44.61M -$57.85M
Interest Income $5.21M $7.14M $9.84M $1.68M $255K $1.84M $8.37M $7.64M $2.67M $736K
Interest Expense -- -- -- -- -- -- -- -- -- $1.69M
Income Before Tax -$17.13M $32.09M $3.32M -$99.32M -$115.9M -$46.80M -$102.7M -$70.30M -$43.61M -$58.92M
Income Tax Expense $238K $224K $3.89M $0 $0 -$13.91M -$427K $14.30M -$513K -$19K
Net Income -$17.37M $31.87M -$569K -$99.32M -$115.9M -$32.88M -$102.2M -$84.60M -$43.10M -$58.90M
Basic EPS -- -- -- -- -- -- -- -- -$1.16 -$1.63
Diluted EPS -- -- -- -- -- -- -- -- -$1.16 -$1.63
Basic Shares Outstanding 137.9M 84.4M 73.8M 65.7M 64.1M 46.1M 45.3M 41.7M 37.2M 36.2M
Diluted Shares Outstanding 137.9M 84.7M 73.8M 65.7M 64.1M 46.1M 45.3M 41.7M 37.2M 36.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $1.69M $1.42M $10.26M $663K $5.96M $18.66M $50.92M $38.09M
Research & Development $16.48M $17.60M $19.24M $21.23M $15.30M $13.32M $18.87M $14.79M
Total Operating Expenses $25.19M $25.20M $29.93M $28.59M $21.73M $19.94M $28.30M $20.41M
Operating Income -$23.50M -$23.78M -$19.67M -$27.93M -$15.77M -$1.29M $22.62M $17.68M
Interest Income $3.27M $3.16M $1.49M $1.48M $1.59M $1.18M $955K $1.28M
Income Before Tax -$19.94M -$20.61M -$18.19M -$26.46M -$14.17M -$91K $23.59M $18.94M
Income Tax Expense $61K $60K $59K $54K $58K $63K $62K $62K
Net Income -$20.00M -$20.67M -$18.25M -$26.51M -$14.23M -$154K $23.52M $18.88M
Basic Shares Outstanding 219.1M 218.9M 177.3M -- 165.0M 129.1M 87.1M --
Diluted Shares Outstanding 219.1M 218.9M 177.3M -- 165.0M 129.1M 87.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $12.67M $38.05M $17.17M $193.7M $205.5M $191.9M $188.4M $247.6M $177.5M $104.6M
Short-Term Investments $124.4M $62.57M $157.3M $0 $99.70M $124.3M $107.7M $188.6M $196.6M --
Cash & Short-Term Investments $137.1M $101.9M $175.4M $95.57M $266.3M $256.3M $279.4M $436.1M $374.1M $181.9M
Accounts Receivable, Net $2.01M $3.10M $3.43M $35.99M $790K $798K $13K $97K $10.14M $2.16M
Total Current Assets $143.9M $107.3M $182.9M $237.1M $310.3M $324.0M $303.3M $445.5M $388.6M $188.1M
Property, Plant & Equipment, Net $1.30M $2.47M $3.96M $5.07M $5.96M $6.95M $7.37M $6.93M $4.22M $4.39M
Goodwill $949K $949K $949K $949K $949K $949K $949K $949K $949K $949K
Other Non-Current Assets $31K $66K $83K $27K $901K $2.17M $2.02M $1.38M $1.35M $2.97M
Total Non-Current Assets $7.64M $13.23M $18.86M $23.79M $29.11M $34.65M $37.95M $11.63M $9.04M $10.98M
Total Assets $151.6M $120.5M $201.8M $260.9M $339.4M $358.7M $341.3M $457.1M $397.6M $199.1M
Accounts Payable $1.30M $1.09M $1.46M $2.81M $2.82M $3.00M $4.16M $5.13M $4.21M $6.60M
Deferred Revenue (Current) $26.88M $67.20M $132.3M $121.3M $40.82M $74.87M $51.38M $52.71M $40.56M $20.35M
Total Current Liabilities $46.62M $85.77M $155.9M $152.6M $77.87M $100.9M $85.59M $97.91M $61.15M $35.77M
Deferred Revenue (Non-Current) $1.59M $26.86M $80.05M $180.1M $243.9M $186.3M $178.9M $225.3M $264.7M $83.80M
Other Non-Current Liabilities $4.35M $4.12M $3.89M $0 -- -- $850K $3.05M $1.90M $566K
Total Non-Current Liabilities $5.94M $35.22M $93.33M $194.0M $262.0M $207.9M $204.6M $228.3M $266.6M $84.88M
Total Liabilities $52.56M $121.0M $249.2M $346.6M $339.9M $308.9M $290.2M $326.2M $327.7M $120.6M
Total Debt (incl. Leases) $4.24M $9.38M $13.97M $18.06M $21.67M $24.87M $27.68M -- -- --
Common Stock $2.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K
Retained Earnings -$711.9M -$691.6M -$723.4M -$722.9M -$623.6M -$450.1M -$417.2M -$315.0M -$219.5M -$176.4M
Accumulated Other Comp. Income $111K $27K $95K $10K -$242K -$47K $57K -$93K -$94K -$27K
Total Stockholders' Equity $99.01M -$456K -$47.45M -$85.75M -$459K -$7.77M $51.11M $130.9M $69.90M $78.48M
Total Equity $99.01M -$456K -$47.45M -$85.75M -$459K -$7.77M $51.11M $130.9M $69.90M $78.48M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $33.96M $17.22M $28.83M $12.67M $34.19M $49.04M $47.60M $38.05M
Short-Term Investments $314.0M $313.1M $317.9M $124.4M $109.4M $109.0M $32.28M $62.57M
Cash & Short-Term Investments $348.0M $330.3M $346.7M $137.1M $143.6M $158.1M $79.90M $101.9M
Accounts Receivable, Net $501K $37.49M $646K $2.01M $1.63M $1.87M $1.96M $3.10M
Total Current Assets $356.0M $373.2M $353.1M $143.9M $149.2M $164.6M $86.63M $107.3M
Property, Plant & Equipment, Net $2.52M $1.08M $1.09M $1.30M $1.72M $1.95M $2.23M $2.47M
Goodwill $949K $949K $949K $949K $949K $949K $949K $949K
Other Non-Current Assets $551K $31K $31K $31K $51K $56K $61K $66K
Total Non-Current Assets $8.63M $8.07M $6.26M $7.64M $9.04M $10.44M $11.87M $13.23M
Total Assets $364.7M $381.2M $359.4M $151.6M $158.3M $175.1M $98.50M $120.5M
Accounts Payable $1.14M $1.94M $1.37M $1.30M $646K $227K $276K $1.09M
Deferred Revenue (Current) $27.41M $24.07M $17.88M $26.88M $22.38M $22.05M $33.23M $67.20M
Total Current Liabilities $45.53M $39.86M $34.02M $46.62M $41.03M $39.22M $50.20M $85.77M
Deferred Revenue (Non-Current) $25.86M $30.62M $979K $1.59M $5.54M $10.24M $16.21M $26.86M
Other Non-Current Liabilities $4.53M $4.47M $4.41M $4.35M $4.30M $4.24M $4.18M $4.12M
Total Non-Current Liabilities $34.26M $39.30M $5.39M $5.94M $9.84M $15.92M $23.25M $35.22M
Total Liabilities $79.79M $79.16M $39.41M $52.56M $50.87M $55.15M $73.45M $121.0M
Total Debt (incl. Leases) $4.39M $5.70M $2.86M $4.24M $5.60M $6.88M $8.15M $9.38M
Common Stock $2.0K $2.0K $2.0K $2.0K $2.0K $2.0K $1.0K $1.0K
Retained Earnings -$770.9M -$750.9M -$730.2M -$711.9M -$682.4M -$668.2M -$668.1M -$691.6M
Accumulated Other Comp. Income -$315K -$196K $102K $111K $104K $33K -$1.0K $27K
Total Stockholders' Equity $284.9M $302.1M $319.9M $99.01M $107.4M $119.9M $25.05M -$456K
Total Equity $284.9M $302.1M $319.9M $99.01M $107.4M $119.9M $25.05M -$456K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$17.37M $31.87M -$569K -$99.32M -$115.9M -$32.88M -$102.2M -$84.60M -$43.10M -$58.90M
Depreciation & Amortization $1.35M $1.75M $2.15M $2.45M $2.75M $2.55M $2.65M $1.88M $1.65M $1.73M
Stock-Based Compensation $6.30M $7.67M $8.56M $13.12M $13.17M $14.79M $19.10M $16.88M $11.29M $10.10M
Change in Receivables $1.09M $329K $32.55M -$35.20M $8.0K -$785K $84K $10.04M -$7.98M -$1.79M
Change in Payables $221K -$297K -$1.43M $68K -$139K -$857K -$374K $261K -$2.44M $1.76M
Operating Cash Flow -$75.59M -$86.23M -$56.03M -$110.8M -$119.0M $5.26M -$140.5M -$75.52M $170.4M -$2.03M
Capital Expenditure -$220K -$310K -$840K -$1.74M -$1.61M -$2.31M -$3.50M -$3.79M -$1.56M -$2.18M
Free Cash Flow -$75.81M -$86.54M -$56.88M -$112.5M -$120.6M $2.95M -$144.0M -$79.31M $168.8M -$4.21M
Purchases of Investments -- -- -- -- -$99.90M -$199.1M -$175.0M -$204.6M -$218.7M -$121.5M
Investing Cash Flow -$59.74M $99.70M -$150.7M $98.26M $22.49M -$18.72M $79.70M $5.93M -$121.3M $45.86M
Common Stock Issued $109.6M $6.91M -- $0 $107.7M $11.29M $0 $134.6M $19.96M --
Financing Cash Flow $110.4M $7.52M $30.23M $648K $110.2M $16.89M $1.63M $139.6M $23.80M $996K
Net Change in Cash -$24.89M $20.99M -$176.5M -$11.88M $13.67M $3.43M -$59.15M $70.03M $72.90M $44.82M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$20.00M -$20.67M -$18.25M -$26.51M -$14.23M -$154K $23.52M $18.88M
Stock-Based Compensation $2.84M $2.58M $4.71M $1.48M $1.38M $1.43M $2.01M $1.88M
Change in Receivables $36.99M -$36.85M $1.37M -$384K $240K $87K $1.15M $249K
Change in Payables -$932K $571K $67K $655K $419K -$49K -$804K -$261K
Operating Cash Flow $16.65M -$18.07M -$25.55M -$23.24M -$15.55M -$15.75M -$21.04M -$19.91M
Capital Expenditure -$589K $0 $0 -$201K $127K -$27K -$119K -$80K
Free Cash Flow $16.06M -$18.07M -$25.55M -$23.44M -$15.42M -$15.78M -$21.16M -$19.99M
Investing Cash Flow -$3.0K $5.95M -$192.8M -$14.42M $439K -$76.36M $30.60M $15.13M
Common Stock Issued $0 $56K $228.4M $16.26M $0 $93.37M $0 --
Financing Cash Flow $94K $511K $234.5M $16.64M $253K $93.55M $0 $2.25M
Net Change in Cash $16.74M -$11.60M $16.16M -$21.02M -$14.86M $1.44M $9.55M -$2.52M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -29.3% 18.1% -6.4% -190.6% -311.0% -48.4% -192.9% -130.9% -64.6% -396.1%
Net Profit Margin -22.8% 23.1% -0.6% -186.8% -310.5% -32.8% -177.8% -142.2% -60.2% -391.5%
Return on Equity (ROE) -17.5% -- -- -- -- -- -200.0% -64.6% -61.7% -75.1%
Return on Assets (ROA) -11.5% 26.4% -0.3% -38.1% -34.1% -9.2% -30.0% -18.5% -10.8% -29.6%
Current Ratio 3.09x 1.25x 1.17x 1.55x 3.98x 3.21x 3.54x 4.55x 6.36x 5.26x
Quick Ratio 2.98x 1.22x 1.15x 0.86x 3.43x 2.55x 3.26x 4.46x 6.28x 5.15x
Debt to Equity 0.04x -- -- -- -- -- 0.54x -- -- --
Revenue Growth (YoY) -44.8% +36.4% +90.4% +42.5% -62.8% +74.6% -3.4% -16.9% +376.1% +95.1%
Operating Income Growth (YoY) -189.5% -- -- -- -- -- -- -- -- --
Net Income Growth (YoY) -154.5% -- -- -- -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -2363.4% -- -- -144.3% -- --
Free Cash Flow Growth (YoY) -- -- -- -- -4189.5% -- -- -147.0% -- --
5Y Revenue / Share Growth -74.6% +29.0% -4.0% -58.0% +40.1% +142.4% -75.3% +24.2% -- --
10Y Revenue / Share Growth -38.4% -68.1% +19.3% -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -676.5% -476.2% -181.9% -29.4% 20.5% 30.6% 24.4% 18.1%
Net Profit Margin -609.0% -435.2% -166.4% -22.8% 24.7% 34.0% 28.2% 23.1%
Return on Equity (ROE) -30.0% -26.4% -18.5% -17.5% 26.1% 40.0% 166.1% --
Return on Assets (ROA) -23.4% -20.9% -16.5% -11.5% 17.7% 27.4% 42.2% 26.4%
Current Ratio 7.82x 9.36x 10.38x 3.09x 3.64x 4.20x 1.73x 1.25x
Quick Ratio 7.65x 9.23x 10.21x 2.98x 3.54x 4.08x 1.63x 1.22x
Debt to Equity 0.02x 0.02x 0.01x 0.04x 0.05x 0.06x 0.33x --
Revenue Growth (YoY) -71.7% -92.4% -79.9% -98.3% -82.2% -25.7% +22.8% +43.2%
Operating Income Growth (YoY) -- -- -187.0% -258.0% -483.6% -- +94.1% --
Net Income Growth (YoY) -- -- -177.6% -240.4% -348.1% -- +70.6% +2155.2%
Source: SEC EDGAR CompanyFacts (CIK 0001501989) · from December 31, 2013 Data through September 30, 2026 · synced Nov 20, 2026, 05:37 UTC · Open in terminal